{"url_path":"/sec/sonm/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1178697/0001493152-26-024644-index.html","accession_number":"0001493152-26-024644","cik":"0001178697","ticker":"SONM","issuer_name":"DNA X, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1178697/0001493152-26-024644-index.html","primary_entity_key":"0001178697","primary_entity_name":"DNA X, Inc."},"word_count":1020,"has_tables":true,"body_markdown":"** **\n\n**Item\n6. Exhibits.**\n\n \n\n \n \n \n \n**Incorporated\nby Reference**\n\n**Exhibit\nNumber**\n \n**Description**\n \n**Form**\n \n**File\nNo.**\n \n**Exhibit\nNumber**\n \n**Filing\nDate**\n\n \n \n \n \n \n \n \n \n \n \n \n\n3.1\n \n[Amended and Restated Certificate of Incorporation of the Registrant.](https://www.sec.gov/Archives/edgar/data/1178697/000119312519149725/d938487dex31.htm)\n \n8-K\n \n001-38907\n \n3.1\n \nMay\n17, 2019\n\n \n \n \n \n \n \n \n \n \n \n \n\n3.2\n \n[Certificate of Amendment to the Amended and Restated Certificate of Incorporation, effective September 15, 2021 (Reverse Stock Split)](https://www.sec.gov/Archives/edgar/data/1178697/000119312521273987/d202279dex31.htm)\n \n8-K\n \n001-38907\n \n3.1\n \nSeptember\n15, 2021\n\n \n \n \n \n \n \n \n \n \n \n \n\n3.3\n \n[Certificate of Amendment to the Amended and Restated Certificate of Incorporation, effective July 17, 2024 (Reverse Stock Split)](https://www.sec.gov/Archives/edgar/data/1178697/000149315224028272/ex3-1.htm)\n \n8-K\n \n001-38907\n \n3.1\n \nJuly\n18, 2024\n\n \n \n \n \n \n \n \n \n \n \n \n\n3.4\n \n[Certificate of Designation of Rights, Preferences and Privileges of Series A Junior Participating Preferred Stock filed with the Secretary of State of the State of Delaware on April 21, 2025](https://www.sec.gov/Archives/edgar/data/1178697/000164117225005546/ex3-1.htm)\n \n8-K\n \n001-38907\n \n3.1\n \nApril\n21, 2025\n\n \n \n \n \n \n \n \n \n \n \n \n\n3.5\n \n[Certificate of Amendment to the Amended and Restated Certificate of Incorporation, effective October 16, 2025 (Increase in authorized shares from 100,000,000 to 1,000,000,000)](https://www.sec.gov/Archives/edgar/data/1178697/000149315225018637/ex3-1.htm)\n \n8-K\n \n001-38907\n \n3.1\n \nOctober\n20, 2025\n\n \n \n \n \n \n \n \n \n \n \n \n\n3.6\n \n[Certificate of Amendment to the Amended and Restated Certificate of Incorporation, effective October 27, 2024 (Reverse Stock Split)](https://www.sec.gov/Archives/edgar/data/1178697/000149315225019183/ex3-1.htm)\n \n8-K\n \n001-38907\n \n3.1\n \nOctober\n24, 2025\n\n \n \n \n \n \n \n \n \n \n \n \n\n3.7\n \n[Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Registrant, effective January 23, 2026](https://www.sec.gov/Archives/edgar/data/1178697/000149315226003824/ex3-1.htm)\n \n8-K\n \n001-38907\n \n3.1\n \nJanuary 27, 2026\n\n \n \n \n \n \n \n \n \n \n \n \n\n3.8\n \n[Amended and Restated Bylaws of the Registrant, as amended and restated as of June 14, 2024](https://www.sec.gov/Archives/edgar/data/1178697/000149315224023873/ex3-1.htm)\n \n8-K\n \n001-38907\n \n3.1\n \nJune 14, 2024\n\n \n \n \n \n \n \n \n \n \n \n \n\n4.1\n \n[Promissory note dated as of February 21, 2025](https://www.sec.gov/Archives/edgar/data/1178697/000149315225007911/ex4-1.htm)\n \n8-K\n \n001-38907\n \n4.1\n \nFebruary\n21, 2025\n\n \n \n \n \n \n \n \n \n \n \n \n\n4.2\n \n[Rights Agreement, dated as of April 21, 2025, by and between Sonim Technologies Inc. and Equiniti Trust Company, LLC, which includes the form Certificate of Designation as Exhibit A, the form of Right Certificate as Exhibit B, and the Summary of Rights to Purchase Preferred Shares as Exhibit C](https://www.sec.gov/Archives/edgar/data/1178697/000164117225005546/ex4-1.htm)\n \n8-K\n \n001-38907\n \n4.1\n \nApril\n21, 2025\n\n \n \n \n \n \n \n \n \n \n \n \n\n4.3\n \n[Form of Common Stock Purchase Warrant, dated as of May 12, 2025, issued by Sonim Technologies, Inc. to the purchasers named therein](https://www.sec.gov/Archives/edgar/data/1178697/000164117225011178/ex4-1.htm)\n \n8-K\n \n001-38907\n \n4.1\n \nMay\n16, 2025\n\n \n \n \n \n \n \n \n \n \n \n \n\n4.4\n \n[Form of Placement Agent Warrant to Purchase Common Stock, issued on July 2, 2025](https://www.sec.gov/Archives/edgar/data/1178697/000164117225017611/ex4-1.htm)\n \n8-K\n \n001-38907\n \n4.1\n \nJuly\n2, 2025\n\n \n \n \n \n \n \n \n \n \n \n \n\n4.5\n \n[Promissory Note dated as of July 11, 2025](https://www.sec.gov/Archives/edgar/data/1178697/000164117225020061/ex4-1.htm)\n \n8-K\n \n001-38907\n \n4.1\n \nJuly\n17, 2025\n\n \n\n32\n\n \n\n \n\n10.1\n \n[Liu Separation and Release Agreement, dated as of January 30, 2026](https://www.sec.gov/Archives/edgar/data/1178697/000149315226005202/ex10-1.htm)\n \n8-K\n \n001-38907\n \n10.1\n \nFebruary\n5, 2026\n\n \n \n \n \n \n \n \n \n \n \n \n\n10.2\n \n[Becher Separation and Release Agreement, dated as of February 3, 2026](https://www.sec.gov/Archives/edgar/data/1178697/000149315226005202/ex10-2.htm)\n \n8-K\n \n001-38907\n \n10.2\n \nFebruary\n5, 2026\n\n \n \n \n \n \n \n \n \n \n \n \n\n10.3†#\n \n[Employment Agreement, dated as of October 16, 2025, by and between DNA X, Inc. and Michael Mulica.](https://www.sec.gov/Archives/edgar/data/1178697/000149315225018637/ex10-1.htm)\n \n8-K\n \n001-38907\n \n10.1\n \nOctober\n20, 2025\n\n \n \n \n \n \n \n \n \n \n \n \n\n10.4†\n \n[First Amendment to Employment Agreement of Mike Mulica, dated as of February 9, 2026.](https://www.sec.gov/Archives/edgar/data/1178697/000149315226005966/ex10-1.htm)\n \n8-K\n \n001-38907\n \n10.1\n \nFebruary\n10, 2026\n\n \n \n \n \n \n \n \n \n \n \n \n\n10.4†#\n \n[Amended and Restated Letter Agreement, dated as of December 8, 2023, by and between DNA X, Inc. and Clay Crolius](https://www.sec.gov/Archives/edgar/data/1178697/000149315223044318/ex10-2.htm)\n \n8-K\n \n001-38907\n \n10.2\n \nDecember\n11, 2023\n\n \n \n \n \n \n \n \n \n \n \n \n\n10.5†\n \n[First Amendment to Employment Agreement, dated as of April 15, 2025, by and between DNA X, Inc. and Clay Crolius](https://www.sec.gov/Archives/edgar/data/1178697/000164117225004972/ex10-1.htm)\n \n8-K\n \n001-38907\n \n10.1\n \nApril 16, 2025\n\n \n \n \n \n \n \n \n \n \n \n \n\n10.6†\n \n[Second Amendment to Employment Agreement of Clay Crolius, dated as of February 9, 2026](https://www.sec.gov/Archives/edgar/data/1178697/000149315226005966/ex10-2.htm)\n \n8-K\n \n001-38907\n \n10.2\n \nFebruary 10, 2026\n\n \n \n \n \n \n \n \n \n \n \n \n\n10.8+#\n \n[Asset Purchase Agreement, dated as of July 17, 2025, by and among the Company, Pace Car Acquisition LLC and Clay Crolius](https://www.sec.gov/Archives/edgar/data/1178697/000164117225020576/ex2-1.htm)\n \n8-K\n \n001-38907\n \n2.1\n \nJuly 22, 2025\n\n \n \n \n \n \n \n \n \n \n \n \n\n10.9\n \n[First Amendment to Asset Purchase Agreement, dated as of November 24, 2025, by and among the Company, Pace Car Acquisition LLC and Clay Crolius](https://www.sec.gov/Archives/edgar/data/1178697/000149315225025141/ex2-1.htm)\n \n8-K\n \n001-38907\n \n2.1\n \nNovember 26, 2025\n\n \n \n \n \n \n \n \n \n \n \n \n\n10.10#\n \n[Second Amendment to Asset Purchase Agreement, dated as of January 23, 2026](https://www.sec.gov/Archives/edgar/data/1178697/000149315226003824/ex2-1.htm)\n \n8-K\n \n001-38907\n \n2.1\n \nJanuary 27, 2026\n\n \n \n \n \n \n \n \n \n \n \n \n\n31.1\n \n[Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31-1.htm)\n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n \n \n \n \n \n\n31.2\n \n[Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31-2.htm)\n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n \n \n \n \n \n\n32.1*\n \n[Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32-1.htm)\n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n \n \n \n \n \n\n32.2*\n \n[Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32-2.htm)\n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n \n \n \n \n \n\n101.INS\n \nInline\nXBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within\nthe Inline XBRL document).\n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n \n \n \n \n \n\n101.SCH\n \nInline\nXBRL Taxonomy Extension Schema Document.\n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n \n \n \n \n \n\n101.CAL\n \nInline\nXBRL Taxonomy Extension Calculation Linkbase Document.\n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n \n \n \n \n \n\n101.DEF\n \nInline\nXBRL Taxonomy Extension Definition Linkbase Document.\n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n \n \n \n \n \n\n101.LAB\n \nInline\nXBRL Taxonomy Extension Label Linkbase Document.\n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n \n \n \n \n \n\n101PRE\n \nInline\nXBRL Taxonomy Extension Presentation Linkbase Document.\n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n \n \n \n \n \n\n104\n \nCover\nPage Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)\n \n \n \n \n \n \n \n \n\n \n\n*\nThe\ncertifications furnished in Exhibits 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are deemed furnished and not\nfiled with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of the Company under\nthe Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date\nof this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.\n\n \n \n\n†\nIndicates\na management contract or compensatory plan or arrangement\n\n \n \n\n#\nSchedules\nhave been omitted in accordance with Item 601(a)(5) of Regulation S-K. The registrant agrees to furnish a copy of all omitted schedules\nto the SEC upon its request.\n\n \n \n\n+\nCertain\nportions of this exhibit (indicated by [***]) have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K because the registrant\nhas determined that such redacted information is not material and is the type that the registrant treats as private or confidential.\n\n \n\n33\n\n \n\n** **\n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned thereunto duly authorized.\n\n \n\n \nDNA\nX, INC.\n\n \n \n \n\nDate:\nMay 20, 2026\nBy:\n*/s/\nMichael Mulica*\n\n \n \n**Michael\nMulica**\n\n \n \n**Acting\nChief Executive Officer**\n\n \n \n**(Principal\nExecutive Officer)**\n\n \n\nDate:\nMay 20, 2026\nBy:\n\n*/s/\nClay Crolius*\n\n \n \n**Clay\nCrolius**\n\n \n \n**Chief\nFinancial Officer**\n\n \n \n**(Principal\nFinancial and Accounting Officer)**\n\n \n\n34\n\n****"}